跳至主要内容
临床试验/NCT05908019
NCT05908019招募中不适用

The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.

National Defense Medical Center, Taiwan1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年5月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
Pulmonary Arterial Hypertension Symptom

研究概览

简要总结

Pulmonary arterial hypertension (PAH) is a chronic disease characterized by an elevation in pulmonary artery pressures and pulmonary vascular resistance. The condition most often is rarely detected, and patients frequently suffer symptoms for several years before being appropriately diagnosed. Patients with PH suffer from several symptoms, such as exertional dyspnea, fatigue, weakness, chest pain, fainting...et al. Pulmonary hypertension is an incurable and progressive disease with complex symptoms and treatments. Patients must learn to deal with their unpredictable future and manage the complex treatments associated with severe adverse effects and need significant changes in lifestyle.

Therefore, it is important to assist patients to develop the ability of symptom management.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 20 years old, diagnosed by clinical specialists as patients with pulmonary hypertension (Group1 and Group 4)
  • Clear consciousness, able to communicate in Mandarin and Taiwanese, with normal hearing
  • Those who have internet or mobile internet at home
  • Adults without mental illness
  • No alcohol or drug abusers.

排除标准

  • critical disease

结局指标

主要结局

Pulmonary Arterial Hypertension Symptom

时间窗: Change from Baseline pulmonary Arterial Hypertension Symptom at six months

Pulmonary Arterial Hypertension Symptom Interference Scale, PAHSS, The 10-point Likert scale higher scores mean a worse outcome.

次要结局

  • Pulmonary Hypertension Quality of life(Change from Baseline quality of life at six months)
  • Activity ability(Change from Baseline activity ability at six months)
  • Social support(Change from Baseline social support at six months)

研究者

发起方
National Defense Medical Center, Taiwan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Miao-Yi Chen

Principal Investigator

National Defense Medical Center, Taiwan

研究点 (1)

Loading locations...

相似试验